Other News To Note
• Erytech Pharma, of Lyon, France, said it entered a definitive agreement granting Orphan Europe, part of the Recordati Group, of Milano, Italy, exclusive rights for the commercialization and distribution of Graspa in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in Europe.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter